Table 1.
Demographic characteristics of study participants.
| Variable | No ALVSD (N=4918) ( Mean ±SD) |
ALVSD (N= 86) (Mean ±SD) |
P value |
|---|---|---|---|
| Age (years) | 61.5 ±10.1 | 62.4 ±10.7 | 0.432 |
| Female (%) | 2607(53.1) | 15(17.4) | <0.0001 |
|
Race/ Ethnicity (%)
Caucasian Chinese African American Hispanics |
1923(39.1) 652(13.3) 1252(25.4) 1091(22.2) |
34(39.5) 1(1.2) 33(38.4) 18(20.9) |
<0.001 |
| BMI( Kg/m2) | 27.7± 4.9 | 28.2 ±4.9 | 0.353 |
| Systolic BP(mmHg) | 125.4 ±21.3 | 129.7 ±22.3 | 0.06 |
| Diastolic BP(mmHg) | 71.7 ±10.3 | 76.9 ±11.6 | <0.001 |
| Diabetes Mellitus (%) | 503(10.2) | 15(17.4) | 0.07 |
|
Cholesterol(mg/dl)
Total LDL HDL Triglycerides |
194.4 ±35.3 117.2± 31.3 51.2 ±15.0 131.1± 85.1 |
191.2± 39.6 115.8 ±32.5 46.8 ±13.1 140.6 ±88.9 |
0.414 0.685 0.006 0.306 |
|
Cigarette Smoking (%)
Never Former Current |
2546(51.9) 1749(35.6) 612(12.5) |
23(27.7) 37(44.6) 23(27.7) |
<0.0001 |
| L V mass index (gm/m2) | 77.5 ± 15.6 | 103.1 ± 29.3 | <0.0001 |
| In(CAC +1) | 2.1 ± 2.5 | 3.1 ± 2.6 | 0.003 |
| Framingham Risk Score | 8.4 ± 8.0 | 13.3 ± 8.8 | <0.001 |
| Any Diuretic (%) | 602 (12.3) | 8(9.3) | 0.408 |
| Beta Blocker Use (%) | 421(8.6) | 5(5.8) | 0.364 |
| STATIN use (%) | 716(14.6) | 11(12.1) | 0.640 |
| ACE Inhibitor Use (%) | 531(10.8) | 14(16.3) | 0.110 |
| BP medication Use (%) | 1541(31.3) | 24(27.9) | 0.496 |
| LVEF (%) | 69.4 ±6.7 | 44.4 ± 6.0 | <0.0001 |